Vioxx users who claim the drug increased their risk of heart ailments may pursue a class action for funding of a medical monitoring program, a New Jersey appeals court has ruled. The three-judge panel, while expressing no opinion on the viability of the product liability claims, ruled that the trial judge had dismissed them too hastily, simply because the plaintiffs had not demonstrated harm. The decision came as the trial judge, Carol Higbee, prepared for her fourth Vioxx trial, set to begin on Monday.
January 18, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Vioxx users who claim the drug increased their risk of heart ailments may pursue their class action suit against Merck & Co. Inc. for funding of a medical monitoring program.
A New Jersey appeals court, while expressing no opinion on the viability of the product liability claims, ruled that the trial judge had dismissed them too hastily, simply because the plaintiffs had not demonstrated harm.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
